Population Pharmacokinetics of Lithium in Young Pediatric Patients With Intellectual Disability

Background: Lithium is a well-established treatment for bipolar disorders and has been shown to be neuroprotective, and thus low doses might be useful for the treatment of childhood brain injury and neurological sequelae. However, pharmacokinetic (PK) data in children are limited. This study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Junying, Zhang, Bohao, Xu, Yiran, Zhang, Xiaoli, Song, Juan, Zhou, Wenhao, Hu, Kai, Zhu, Dengna, Zhang, Lirong, Shao, Fengmin, Zhang, Shusheng, Ding, Junjie, Zhu, Changlian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082156/
https://www.ncbi.nlm.nih.gov/pubmed/33935755
http://dx.doi.org/10.3389/fphar.2021.650298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082156/
https://www.ncbi.nlm.nih.gov/pubmed/33935755
http://dx.doi.org/10.3389/fphar.2021.650298

Ejemplares similares